Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-Vs-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02915887
What this trial is testing

The Effect of Cervical Taping on Neck Pain and Kinematics in Patients With Chronic Neck Pain

Who this might be right for
Neck PainCervical PainChronic Pain
University of Haifa 27
Testing effectiveness (Phase 2)WithdrawnNCT05567406
What this trial is testing

Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

Who this might be right for
Chronic Graft Versus Host Disease
Kadmon, a Sanofi Company
Large-scale testing (Phase 3)Looking for participantsNCT07395232
What this trial is testing

An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

Who this might be right for
Atopic Keratoconjunctivitis
Dompé Farmaceutici S.p.A 153
Testing effectiveness (Phase 2)Study completedNCT01063907
What this trial is testing

KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 95
Not applicableStudy completedNCT01738464
What this trial is testing

Microbiomes of Pelvic Pain

Who this might be right for
Interstitial CystitisChronic ProstatitisChronic Pelvic Pain Syndrome+3 more
Northwestern University 91
Very early researchLooking for participantsNCT06920199
What this trial is testing

Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2

Who this might be right for
cGVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 18
Post-approval studies (Phase 4)Study completedNCT02286063
What this trial is testing

Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)

Who this might be right for
Lung; Disease, Fibroid (Chronic)
Royal Brompton & Harefield NHS Foundation Trust 70
Testing effectiveness (Phase 2)Looking for participantsNCT07509749
What this trial is testing

Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)

Who this might be right for
GVHD, AcuteStem Cell Transplant Complications
Daihong Liu 54
Testing effectiveness (Phase 2)Study completedNCT00431873
What this trial is testing

A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Mirati Therapeutics Inc. 21
Large-scale testing (Phase 3)WithdrawnNCT00006451
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Masonic Cancer Center, University of Minnesota
Not applicableLooking for participantsNCT05866302
What this trial is testing

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Who this might be right for
Chronic Lung DiseaseHematopoietic Cell TransplantationGraft Versus Host Disease
University of Michigan Rogel Cancer Center 375
Testing effectiveness (Phase 2)Study completedNCT02498327
What this trial is testing

The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency

Who this might be right for
Venous Insufficiency
University of Johannesburg 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03077542
What this trial is testing

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 57
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Large-scale testing (Phase 3)Study completedNCT03112603
What this trial is testing

Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 330
Not applicableEnded earlyNCT05655546
What this trial is testing

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Who this might be right for
ImmunodeficiencyImmunosuppressionHIV Infections+7 more
Scripps Translational Science Institute 2,117
Testing effectiveness (Phase 2)Looking for participantsNCT06815003
What this trial is testing

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT07118254
What this trial is testing

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

Who this might be right for
Ocular Graft Versus Host Disease
Lubris Bio Pty Ltd 15
Testing effectiveness (Phase 2)Study completedNCT02683525
What this trial is testing

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Sherif S. Farag 37
Not applicableStudy completedNCT00088543
What this trial is testing

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Graft vs. Host Disease (GvHD)
Genzyme, a Sanofi Company 60
Next Page